Press release
Antithrombotic Drugs Market Poised to Reach USD 105.33 Billion by 2032, Expanding at a 8.1% CAGR | Key Players- Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company
๐๐๐๐จ๐ซ๐๐ข๐ง๐ ๐ญ๐จ ๐๐ง ๐๐ฑ๐ก๐๐ฎ๐ฌ๐ญ๐ข๐ฏ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐ง๐ญ๐ข๐ญ๐ก๐ซ๐จ๐ฆ๐๐จ๐ญ๐ข๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐ฉ๐จ๐ข๐ฌ๐๐ ๐๐จ๐ซ ๐ฌ๐ข๐ ๐ง๐ข๐๐ข๐๐๐ง๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ฏ๐๐ซ ๐ญ๐ก๐ ๐ง๐๐ฑ๐ญ ๐๐๐๐๐๐. ๐๐ง ๐๐๐๐, ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฌ๐๐ฅ๐๐ฌ ๐ข๐ง๐๐จ๐ฆ๐ ๐ซ๐๐๐๐ก๐๐ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง. ๐๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐จ๐จ๐ฌ๐ญ ๐๐ญ ๐ ๐ซ๐จ๐๐ฎ๐ฌ๐ญ ๐๐๐๐ ๐จ๐ ๐.๐%, ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐๐๐ก ๐๐๐ ๐๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐.Antithrombotic drugs predominantly comprise antiplatelet agents, fibrinolytic drugs, and anticoagulants. By acknowledging the category of thrombus, one can establish productive therapy. That is, arterial thrombus should be cured by antiplatelet agents, and venous thrombosis should be cured by anticoagulants predominantly. However, they do not dissolve the clot that has already been configured. They prohibit thrombus augmentation, outbreak, and embolic intricacies.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/request-for-sample
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ ๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ง๐ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ
โข The market for antithrombotic drugs is expanding due to the existence of antithrombotic/anticoagulant medications.
โข The market has grown due to the countries' maturing population profiles. As per the estimates dependent on data from the Population Reference Bureau, the aggregate of people crossing 65 escalated worldwide from beneath 450 million to 601 million between 2014 and 2017, a 33% escalation. Covering the longevity of the projection, the escalation is expected to continue.
โข The growing incidences of detrimental illnesses such as cancer, hypertension, and heart-connected illnesses are causing the antithrombotic drugs market to grow rapidly. The number one terminator globally, cardiovascular diseases professes the lives of 17.9 million people yearly. More than four out of every five CVD terminations are credited to strokes and heart attacks, with one-third of those deaths taking place prior to the age of 70.
๐๐จ๐ฆ๐ฉ๐๐ง๐ฒ ๐๐ซ๐จ๐๐ข๐ฅ๐
The market is excessively aggressive, with many local and regional players. Major companies in the antithrombotic drugs market are noted below:
โข Bristol-Myers Squibb Company
โข AstraZeneca plc
โข Eli Lilly and Company
โข C.H. Boehringer Sohn AG & Ko. KG and Aspen Bayer AG
โข Pfizer
โข Johnson & Johnson. AstraZeneca
โข Otsuka Pharmaceutical
โข Portola Pharmaceutical Inc.
โข Yuyu Pharma Inc.
โข Daiichi Sankyo Company
โข Limited
โข Glenmark Pharmaceuticals Limited
โข China National Pharmaceutical Group Corp
โข Novartis
โข Acetlion Pharmaceuticals
โข Generium Holdings
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐ฉ๐ฎ๐ซ๐๐ก๐๐ฌ๐: https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/inquire-before-buying
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐๐จ๐ฉ๐
โข North America (Canada, United States, Mexico)
โข Europe (Spain, Germany, France, United Kingdom, Italy, Rest of Europe)
โข Asia-Pacific (China, Australia, India, South Korea, Japan, Rest of Asia-Pacific)
โข Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa)
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
Antithrombotic Drugs market, By Drug Type (Revenue - USD Billion, 2019-2032)
โข Antiplatelet Drug
โข Anticoagulant Drug
โข Thrombolytic Drug
Antithrombotic Drugs market, By Route of Administration (Revenue - USD Billion, 2019-2032)
โข Oral
โข Parenteral
Antithrombotic Drugs market, By Application (Revenue - USD Billion, 2019-2032)
โข Pulmonary Embolism
โข Deep Vein Thrombosis
โข Atrial Fibrillation
โข Others
Antithrombotic Drugs market, By End User (Revenue - USD Billion, 2019-2032)
โข Hospitals
โข Ambulatory Surgery Centres
โข Emergency Service Centres
โข Others
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ญ๐ก๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐: https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market
๐๐ง๐ญ๐ข๐ญ๐ก๐ซ๐จ๐ฆ๐๐จ๐ญ๐ข๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข Antiplatelet drugs are expected to dominate the market due to increasing use for clotting as arterial clots comprised primarily of platelets, antiplatelet medications are most effective.
โข Activities by key players in the market for the development of antiplatelet drugs are expected to drive the market growth over the forecast period.
โข Anticoagulant, Thrombolytic, and oral drugs is expected to hold the largest market share during the forecast period. Anticoagulants work by interfering with several blood coagulation pathways, making them closely connected to antiplatelet medications and thrombolytic therapies.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐๐'๐ฌ ๐๐ฑ๐ญ๐๐ง๐ฌ๐ข๐ฏ๐ ๐จ๐ง๐ ๐จ๐ข๐ง๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐จ๐ฆ๐๐ข๐ง:
Titanium & Titanium Alloys Dental Implants Market: https://www.polarismarketresearch.com/industry-analysis/titanium-and-titanium-alloys-dental-implants-market
Onychomycosis Market: https://www.polarismarketresearch.com/industry-analysis/onychomycosis-market
Muscle Stimulator Market: https://www.polarismarketresearch.com/industry-analysis/muscle-stimulator-market
Subcutaneous Drug Delivery Devices Market: https://www.polarismarketresearch.com/industry-analysis/subcutaneous-drug-delivery-devices-market
๐๐จ๐ง๐ญ๐๐๐ญ:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antithrombotic Drugs Market Poised to Reach USD 105.33 Billion by 2032, Expanding at a 8.1% CAGR | Key Players- Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company here
News-ID: 3669004 • Views: โฆ
More Releases from Polaris Market Research & Consulting

Salmon Fish Market Size to Reach $35.50 Billion by 2032, Driven by 8.3% CAGR
๐๐๐ฅ๐ฆ๐จ๐ง ๐
๐ข๐ฌ๐ก ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฌ๐๐ฅ๐ฆ๐จ๐ง ๐๐ข๐ฌ๐ก ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide salmon fish industry. Comprehensive analyses of sales volume, price, revenue, market share, and important companiesโฆ

Global Milking Robots Market Expected to Top USD 7,474.68 Million By 2032, Growi โฆ
๐๐ข๐ฅ๐ค๐ข๐ง๐ ๐๐จ๐๐จ๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ก๐ ๐ฆ๐ข๐ฅ๐ค๐ข๐ง๐ ๐ซ๐จ๐๐จ๐ญ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. ๐๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐๐๐ ๐,๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐๐ฑ๐ก๐ข๐๐ข๐ญ๐ข๐ง๐ ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ ๐จ๐ ๐๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง
Milking robots are automatic milking systems where milking is carried out in the absence of instant engagement of an operator. The cows are milked all through the day involving one or twoโฆ

Computer Aided Engineering (CAE) Market Size to Surge to US$ 22.68 Billion Achie โฆ
๐๐จ๐ฆ๐ฉ๐ฎ๐ญ๐๐ซ ๐๐ข๐๐๐ ๐๐ง๐ ๐ข๐ง๐๐๐ซ๐ข๐ง๐ (๐๐๐)-๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐จ๐ฆ๐ฉ๐ฎ๐ญ๐๐ซ ๐๐ข๐๐๐ ๐๐ง๐ ๐ข๐ง๐๐๐ซ๐ข๐ง๐ (๐๐๐) ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide computer aided engineering (CAE) industry. Comprehensive analyses of sales volume, price, revenue,โฆ

Encryption Software Market is Ready to Grow to US$ 26.34 Billion by 2032 With a โฆ
๐๐ง๐๐ซ๐ฒ๐ฉ๐ญ๐ข๐จ๐ง ๐๐จ๐๐ญ๐ฐ๐๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐ง๐๐ซ๐ฒ๐ฉ๐ญ๐ข๐จ๐ง ๐ฌ๐จ๐๐ญ๐ฐ๐๐ซ๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide encryption software industry. Comprehensive analyses of sales volume, price, revenue, market share, and important companiesโฆ
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โAlcohol Testing And Drug Testing Equipment marketโ, detailing every single market driver and intricately analyzing the business vertical. This โAlcohol Testing And Drug Testing Equipment marketโ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drugโฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymeraseโฆ
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
โฆ
AstraZenecaโs NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devicโs disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioningโฆ
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and โฆ
This yearโs 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drugโฆ